APA (7th ed.) Citation

Park, H., Kim, D. Y., Kim, S., Chung, H., Cho, H., Jang, J. E., . . . Kim, J. S. (2018). HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma. Cancer research and treatment, 50(4), 1121-1129. https://doi.org/10.4143/crt.2017.329

Chicago Style (17th ed.) Citation

Park, Hyunsung, et al. "HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis After Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma." Cancer Research and Treatment 50, no. 4 (2018): 1121-1129. https://doi.org/10.4143/crt.2017.329.

MLA (9th ed.) Citation

Park, Hyunsung, et al. "HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis After Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma." Cancer Research and Treatment, vol. 50, no. 4, 2018, pp. 1121-1129, https://doi.org/10.4143/crt.2017.329.